Lescarden, Inc. is a publicly-owned biotechnology company focused on the development of natural biologic therapies for the chronic wound care,
dermatology and osteoarthritis markets. Lescarden’s research team, led for many years by one of its founders, Dr. John Prudden, is responsible for
the breakthrough studies conducted with bovine cartilage. These efforts brought the Lescarden team to the successful development of Catrix, a
product that is recognized for its therapeutically diverse applications, both systemic and topical. These applications include:
All products should be used as directed on the product container. Use of any product that cuases irritation (redness, itching, scaling, soreness) not described on the product container should be discontinued. The information provided at SkinCareWorldWide.com is not a substitute for a face-to-face consultation with a dermatologist or your physician and should not be construed as individual medical advice. SkinCareWorldWide.com does not give individual medical advice by phone or by em-mail.
list view
grid view
